Maryland Biopharma Raises $105 Million in Series D to Fund Development of RNAi Therapeutics
By T. Chakraborty, Ph.D. Sirnaomics, Inc., a leading biopharmaceutical company based in Maryland, focuses on developing novel therapeutics using RNAi technology. On October 22nd, the company announced that it had …
Read More